Homogeneous time-resolved fluorescence and its applications for kinase assays in drug discovery.
The rapidly growing interest in kinases as potential targets for therapeutic intervention has prompted the development of many kinase assay technologies. One exciting example is homogeneous time-resolved fluorescence (HTRF). An HTRF assay utilizes the signal generated by the fluorescence resonance energy transfer between donor and acceptor molecules in close proximity. Dual-wavelength detection helps to eliminate media interference, and the final signal is proportional to the extent of product formation. Thus far, the reported applications of this technology for in vitro kinase assays have mainly focused on high-throughput screening. In this report, we extend the applications of HTRF technology to the areas of enzyme and inhibitor characterization, some aspects of which were previously believed impossible. We describe the methods developed for determining the kinetic parameters of an enzyme, such as K(m) and k(cat), and the procedures for inhibitor mechanistic studies including ATP competitiveness and slow-binding and dissociation kinetics. These assays can be readily applied to any kinase and are valuable in advancing a program through the early stages of drug discovery.
Jia
Yong
Y
Department of Molecular Pharmacology, Abbott Bioresearch Center, Worcester, MA 01605, USA. yong.jia@abbott.com
Quinn
Christopher M
CM
Gagnon
Andrew I
AI
Talanian
Robert
R
D000255:Adenosine Triphosphate / Q000378:metabolism / Q000494:pharmacology; D002384:Catalysis / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D031541:Fluorescence Resonance Energy Transfer / Q000379:methods*; D007093:Imidazoles / Q000494:pharmacology; D007700:Kinetics; D009281:Naphthalenes / Q000494:pharmacology; D010770:Phosphotransferases / Q000037:antagonists & inhibitors / Q000737:chemistry / Q000378:metabolism*; D011720:Pyrazoles / Q000494:pharmacology; D011725:Pyridines / Q000494:pharmacology; D015203:Reproducibility of Results; D013997:Time Factors; D010671:Phenylurea Compounds
D000255:Adenosine Triphosphate; D007093:Imidazoles; D009281:Naphthalenes; D010770:Phosphotransferases; D011720:Pyrazoles; D011725:Pyridines; C452139:doramapimod; D010671:Phenylurea Compounds; C093642:SB 203580